CMS’s Dialysis Facility Care Compare on Medicare.gov offers star ratings and patient survey data to improve transparency and inform decisions on dialysis care quality. The new Provider Data Catalog enhances data access for stakeholders.
Explore the role of Medicare's NCCI Medically Unlikely Edits (MUEs) in regulating Part B claims, detailing guidelines for units of service and updates on edit files by CMS to ensure proper billing compliance.
CMS revises competitive bidding program for durable medical equipment, affecting supply contracts and patient access concerns within Medicare's medical device market.
CMS's Medicare Advantage proposal reintroduces the reward factor, affecting insurer payments by $13B, and phases out the inpatient-only list, impacting outpatient care and rural health strategies.
CMS announces reduced prices for 15 key Medicare Part D drugs starting in 2027, following the Inflation Reduction Act negotiations, targeting major cost savings in Medicare spending.
Geisinger Health Plan earns 2026 Best Insurance Company for Medicare Advantage in Pennsylvania, recognized for high-quality coverage and member services based on CMS quality measures.
CMS proposes to revamp Medicare Advantage Star Ratings, affecting insurer compliance and operations. Legal appeals and health system updates also impact the US market.
Medicare 2026 premiums surge nearly 10%, with fewer Medicare Advantage plans as insurers scale back. Explore key Medicare cost drivers and market impacts.
CMS unveils the GENERous Medicaid payment model introducing MFN drug pricing, alongside expanded Trump administration drug pricing agreements and key regulatory updates for 2026.
The U.S. government passed H.R. 5371, ending the shutdown and extending Medicare telehealth flexibilities through January 2026, ensuring continued coverage and retroactive payments for telehealth claims.
